Complix's Grant - III Round

Complix raised a round of funding on December 14, 2017. Investors include VLAIO.

Complix is a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called Alphabodies, that mainly focus on oncology and autoimmune diseases. Alphabodies are a class …

Articles about Complix's Grant - III Round: